press releases

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in...

Jan 21, 2025

Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve therapeutic...

Dec 12, 2024

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE...

Nov 20, 2024